Management of Penile Atrophy and Painful Erections in Transgender Women on HRT
Direct Recommendation
Topical testosterone is the appropriate choice for this patient to reduce pain and preserve penile tissue for future vaginoplasty, as topical estradiol does not increase penile tissue dimensions and may actually worsen atrophy. 1
Rationale and Evidence
Why Topical Testosterone is Preferred
Topical testosterone significantly increases penile diameter, length, and glans diameter when applied to penile skin, which directly addresses both tissue preservation goals and may reduce pain from atrophy 1
In a randomized controlled trial, 1% testosterone propionate applied twice daily for 30 days increased penile biometric measurements, whereas 0.01% estradiol showed no change in any penile measurements 1
Testosterone application to penile skin achieves marked elevation of local tissue effects without necessarily causing systemic testosterone elevation that would counteract feminizing HRT 2
Why Topical Estradiol Should Be Avoided
Estradiol actively inhibits penile erection, particularly at the penile base, which would likely worsen rather than improve painful erections 3
Research demonstrates that elevated estradiol levels show a negative correlation with erection time and quality, with more pronounced inhibitory effects on penile base function 3
Neonatal estrogen exposure causes permanent penile dysmorphogenesis including replacement of smooth muscle and cavernous spaces with fat cells in the corpus cavernosum, suggesting estradiol promotes tissue atrophy rather than preservation 4
Topical estradiol (0.01%) is FDA-approved only for vulvar and vaginal atrophy in postmenopausal women, not for penile tissue 5
Practical Implementation
Application Protocol
Apply 1% testosterone propionate cream to the entire penis twice daily 1
Treatment duration should be at least 30 days to see biometric changes, though longer periods (3+ months) may provide additional regenerative effects 1, 2
This can be continued intermittently or as needed leading up to surgery, as the Endocrine Society guidelines recommend at least 1 year of consistent hormone therapy before genital surgery 6
Expected Side Effects and Monitoring
Most common side effects are appearance of pubic hair and darkening of genital skin, which are transient and resolve within 90 days of discontinuation 1
These local effects do not typically cause significant changes in serum hormone levels 1
The localized application minimizes systemic absorption that would interfere with feminizing HRT goals 2
Important Caveats
Pain from erections may have multiple etiologies - if pain persists despite improved tissue quality, consider that estrogen-induced changes in pain processing may be contributing, as gender-affirming hormone therapy can create new pain or worsen existing pain 7
Coordinate this approach with the surgeon who will perform vaginoplasty, as they may have specific preferences for preoperative penile tissue management 6
Continue systemic feminizing HRT as prescribed, since the topical testosterone is for local tissue preservation only and should not interfere with overall transition goals 6